If granted the Controlled Activities Regulations (CAR) licence will enable the company to operate 12 x 120 m circumference pens at a maximum biomass of 2,500 tonnes within a 75m x 70m mooring matrix.
Scalpay lies between Skye and the Scottish mainland and the application for the site also seeks permission to use a number of therapeutants against sea lice – bath treatments Cypermethnn, Deltamethrin and Azamethiphos, as well as the in-feed medicine Emamactin Benzoate.
AutoDepomod modelling has been performed to indicate that the development will adhere to the Scottish Environment Protection Agency’s Environmental Quality Standards (EQS).
